Patient characteristics in MGUS-L and non-GUS-L MM in the training set
| Characteristics . | MGUS-L, % . | Non-MGUS-L, % . | P . |
|---|---|---|---|
| n | 101 | 250 | — |
| B2M ≥ 3.0 mg/L† | 33 | 56 | < .001 |
| Cytogenetic abnormalities | 17 | 42 | < .001 |
| Subgroups with poor prognosis* | 22 | 43 | .001 |
| LDH ≥ upper limit of normal | 12 | 26 | .005 |
| Plasma-cell aspirate > 30% | 56 | 70 | .018 |
| Characteristics . | MGUS-L, % . | Non-MGUS-L, % . | P . |
|---|---|---|---|
| n | 101 | 250 | — |
| B2M ≥ 3.0 mg/L† | 33 | 56 | < .001 |
| Cytogenetic abnormalities | 17 | 42 | < .001 |
| Subgroups with poor prognosis* | 22 | 43 | .001 |
| LDH ≥ upper limit of normal | 12 | 26 | .005 |
| Plasma-cell aspirate > 30% | 56 | 70 | .018 |